drugset / Trial / NCT02216838

Treatment of Facial Flushing With Botulinum Toxin A Injections

NCT02216838 ↗

Phase 4 Active not recruiting 16 enrolled Northwestern University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat facial flushing. This study is a pilot study designed to determine feasibility of these procedures.

Timeline

Start
2014-08
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 iu —